Caseware UK (AP4) 2024.0.164 2024.0.164 2025-09-302025-09-30The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.No description of principal activityfalsefalse2024-10-0111truefalse 14340849 2024-10-01 2025-09-30 14340849 2023-10-01 2024-09-30 14340849 2025-09-30 14340849 2024-09-30 14340849 c:Director1 2024-10-01 2025-09-30 14340849 d:CurrentFinancialInstruments 2025-09-30 14340849 d:CurrentFinancialInstruments 2024-09-30 14340849 d:CurrentFinancialInstruments d:WithinOneYear 2025-09-30 14340849 d:CurrentFinancialInstruments d:WithinOneYear 2024-09-30 14340849 d:ShareCapital 2025-09-30 14340849 d:ShareCapital 2024-09-30 14340849 d:RetainedEarningsAccumulatedLosses 2025-09-30 14340849 d:RetainedEarningsAccumulatedLosses 2024-09-30 14340849 c:FRS102 2024-10-01 2025-09-30 14340849 c:AuditExemptWithAccountantsReport 2024-10-01 2025-09-30 14340849 c:FullAccounts 2024-10-01 2025-09-30 14340849 c:PrivateLimitedCompanyLtd 2024-10-01 2025-09-30 14340849 2 2024-10-01 2025-09-30 14340849 e:PoundSterling 2024-10-01 2025-09-30 iso4217:GBP xbrli:pure

Registered number: 14340849









FLOWER ANAESTHESIA LIMITED







UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 30 SEPTEMBER 2025

 
FLOWER ANAESTHESIA LIMITED
 
 
  
CHARTERED ACCOUNTANT'S REPORT TO THE DIRECTOR ON THE PREPARATION OF THE UNAUDITED STATUTORY FINANCIAL STATEMENTS OF FLOWER ANAESTHESIA LIMITED
FOR THE YEAR ENDED 30 SEPTEMBER 2025

In order to assist you to fulfil your duties under the Companies Act 2006, I have prepared for your approval the financial statements of Flower Anaesthesia Limited for the year ended 30 September 2025 which comprise the Balance sheet and the related notes from the Company's accounting records and from information and explanations you have given me.

As a practising member of the Institute of Chartered Accountants in England and Wales (ICAEW)I am subject to its ethical and other professional requirements which are detailed at https://www.icaew.com /regulation.

This report is made solely to the director of Flower Anaesthesia Limited in accordance with the terms of my engagement letter dated 03/06/2024My work has been undertaken solely to prepare for your approval the financial statements of Flower Anaesthesia Limited and state those matters that I have agreed to state to the director of Flower Anaesthesia Limited in this report in accordance with ICAEW Technical Release TECH07/16AAF. To the fullest extent permitted by law, I do not accept or assume responsibility to anyone other than Flower Anaesthesia Limited and its director for my work or for this report. 

It is your duty to ensure that Flower Anaesthesia Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of Flower Anaesthesia Limited. You consider that Flower Anaesthesia Limited is exempt from the statutory audit requirement for the year.

I have not been instructed to carry out an audit or review of the financial statements of Flower Anaesthesia Limited. For this reason, I have not verified the accuracy or completeness of the accounting records or information and explanations you have given to me and I do not, therefore, express any opinion on the statutory financial statements.

  



Drennan & Co
 
Chartered Accountants
  
64 Belsize Park
London
NW3 4EH
2 December 2025
Page 1

 
FLOWER ANAESTHESIA LIMITED
REGISTERED NUMBER: 14340849

BALANCE SHEET
AS AT 30 SEPTEMBER 2025

2025
2024
Note
£
£

  

Current assets
  

Debtors: amounts falling due within one year
 4 
59,122
57,527

Cash at bank and in hand
 5 
119,848
26,207

  
178,970
83,734

Creditors: amounts falling due within one year
 6 
(26,219)
(16,418)

Net current assets
  
 
 
152,751
 
 
67,316

Total assets less current liabilities
  
152,751
67,316

  

Net assets
  
152,751
67,316


Capital and reserves
  

Called up share capital 
  
1
1

Profit and loss account
  
152,750
67,315

  
152,751
67,316


The director considers that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of comprehensive income in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 2 December 2025.




Dr. R. Flower
Director

The notes on pages 4 to 6 form part of these financial statements.
Page 2

 
FLOWER ANAESTHESIA LIMITED
REGISTERED NUMBER: 14340849
    
BALANCE SHEET (CONTINUED)
AS AT 30 SEPTEMBER 2025


Page 3

 
FLOWER ANAESTHESIA LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2025

1.


General information

The entity is a limited company registered in England and Wales.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The following principal accounting policies have been applied:

 
2.2

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Rendering of services

Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the contract;
the stage of completion of the contract at the end of the reporting period can be measured reliably; and
the costs incurred and the costs to complete the contract can be measured reliably.

 
2.3

Interest income

Interest income is recognised in profit or loss using the effective interest method.

 
2.4

Taxation

Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company operates and generates income.


Page 4

 
FLOWER ANAESTHESIA LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2025

2.Accounting policies (continued)

 
2.5

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.6

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

 
2.7

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.


3.


Employees

The average monthly number of employees, including directors, during the year was 1 (2024 - 1).


4.


Debtors

2025
2024
£
£


Other debtors
59,122
57,527

59,122
57,527



5.


Cash and cash equivalents

2025
2024
£
£

Cash at bank and in hand
119,848
26,207

119,848
26,207


Page 5

 
FLOWER ANAESTHESIA LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2025

6.


Creditors: Amounts falling due within one year

2025
2024
£
£

Corporation tax
25,219
15,518

Accruals and deferred income
1,000
900

26,219
16,418


Page 6